Circulating CD34+VEGFR-2+ Endothelial Progenitor Cells Correlate with Revascularization-Mediated Long-Term Improvement of Cardiac Function in Patients with Coronary Chronic Total Occlusions
Yuxiang Dai,Jia Huang,Yinyin Chen,Shufu Chang,Chenguang Li,Hao Lu,Daoyuan Ren,Feng Zhang,Zheyong Huang,Juying Qian,Lei Ge,Junbo Ge
DOI: https://doi.org/10.1016/j.ijcard.2020.08.031
IF: 4.039
2021-01-01
International Journal of Cardiology
Abstract:Background: Endothelial progenitor cells (EPCs) participate in angiogenesis and neocollateralization. This study assessed if circulating EPCs can predict long-term improvement of global left ventricular systolic function in patients with coronary chronic total occlusions (CTOs) underwent successful percutaneous coronary intervention (PCI). Methods: In this single-center, prospective, observational study, 115 consecutive patients with CTOs were evaluated by standard transthoracic echocardiography (ECHO) before and 9-12 months after PCI. Numbers of circulating putative EPCs were determined by flow cytometry analysis of mononuclear cells isolated from peripheral blood samples drawn before and 72 h after PCI. Results: At mean 11.3 +/- 2.5 months post vs. before PCI (all P < .05): by SAQ-7 summary scores, angina frequency, physical limitation and quality of life scores were greater; by ECHO, LVEDd decreased and LVEF increased, which were more significant in patients with Rentrop grades 2/3 vs. 0/1. At 72 h post vs. before PCI, CD34(+)VEGFR2(+)CD133(-) (0.82 +/- 0.32 x 10(6)/L vs. 1.00 +/- 0.39 x 10(6/)L, P = .003), CD34(+)VEGFR-2(+)CD133(+) (0.24 +/- 0.12 x 10(6)/L vs. 0.27 +/- 0.14 x 10(6)/L, P = .028), and CD14(+)Tie2(+)VEGFR-2(+) (6.60 +/- 3.32 x 10(6)/L vs. 7.82 +/- 3.91 x 10(6)/L, P = .006) cell numbers were lower. The baseline levels of CD34(+)VEGFR-2(+)cells (P = .001) and CD14(+)Tie2(+)VEGFR-2(+)cells (P < .001) were association with the grade of collateralization. In addition, the baseline and peri-procedural decrease of circulating CD34(+)VEGFR-2(+) cells correlated with the increase of LVEF (P < .001, P < .001, respectively) and the decrease of LVEDd (P = .022, P = .029, respectively) at follow-up. Conclusions: In this small study, the baseline levels of circulating CD34(+)VEGFR-2(+) EPCs and its reduction after successful revascularization of CTOs correlated with long-term improvement in global LV systolic function. (C) 2020 Elsevier B.V. All rights reserved.